Veloxa Industries IPO Review: GMP, Financials & Valuation Analysis
Veloxa Industries is bringing a ₹1,240 crore mainboard issue with strong 15.7% GMP. Here is a breakdown of its financial growth, valuation vs peers, and key risks.
Published on · Verified Analysis
Editorial Key Takeaways
This analysis is based on official Draft Red Herring Prospectus (DRED) filings, historical peer valuation multiples, and exchange data. Figures are audited for institutional accuracy.
In This Article
Veloxa Industries has opened its ₹1,240 crore mainboard initial public offering, making it one of the largest specialty chemical issues of the quarter.
With a price band of ₹412 to ₹434 per share and an active grey market premium hovering around ₹68 (15.7%), retail and institutional interest has built up rapidly. In this review, we examine the company's financial trajectory, valuation metrics compared to listed peers, and key operational risks.
Company Overview & Business Model
Founded in 2005 and operating out of Vadodara, Gujarat, Veloxa Industries manufactures specialty performance chemicals used in agrochemical, pharmaceutical, and high-performance coating formulations.
The company operates three manufacturing facilities in Gujarat, with a fourth unit currently under development in Dahej. Over 60% of its revenue is anchored by long-term customer contracts, serving over 140 domestic and global clients across 20 countries.
Financial Performance Track Record
Veloxa has demonstrated steady top-line and bottom-line growth over the past three fiscal years:
| Fiscal Year | Revenue (₹ Cr) | Profit After Tax (₹ Cr) | Total Assets (₹ Cr) | PAT Margin |
|---|---|---|---|---|
| **FY24** | ₹980 Cr | ₹96 Cr | ₹1,840 Cr | 9.8% |
| **FY25** | ₹1,120 Cr | ₹128 Cr | ₹2,210 Cr | 11.4% |
| **FY26** | ₹1,340 Cr | ₹162 Cr | ₹2,640 Cr | 12.1% |
Revenue has grown at a 19% CAGR, while profit after tax (PAT) margins expanded from 9.8% in FY24 to 12.1% in FY26 due to higher capacity utilization and backward integration of key chemical intermediates.
Valuation & Peer Comparison
At the upper price band of ₹434, the company commands a post-issue market capitalization of ₹4,120 crore.
| Company Name | Post-IPO P/E | ROE (%) | Annual Revenue |
|---|---|---|---|
| **Veloxa Industries** | **24.1x** | **18.6%** | **₹1,340 Cr** |
| Anupam Rasayan | 38.4x | 14.2% | ₹1,340 Cr |
| Navin Fluorine | 45.7x | 12.8% | ₹1,890 Cr |
| Vinati Organics | 41.2x | 19.4% | ₹2,010 Cr |
At 24.1x post-issue P/E, Veloxa is priced at a reasonable discount to established peers like Anupam Rasayan (38.4x) and Vinati Organics (41.2x), providing a margin of safety for long-term investors.
Key Investment Strengths & Risks
Strengths
Key Risks
Summary Verdict
Veloxa Industries combines a solid 19% growth trajectory, expanding margins, and reasonable valuation relative to its peer group. While raw material fluctuations remain a watchpoint, the ₹68 (15.7%) grey market premium reflects positive institutional and retail sentiment.
*Nothing here is investment advice. IPO investing carries risk, including the risk of listing below issue price. Consult a SEBI-registered adviser before making any investment decision.*
About IPOSathi Research
Primary Market Analyst & Senior Financial Journalist · IPO Latest Updates Daily
Our research desk specializes in reading SEBI Red Herring Prospectuses, institutional anchor allocations, and forensic balance sheet audits. Every report follows rigorous E-E-A-T research standards without promoter sponsorship.